Institute of Human Genetics of the Polish Academy of Sciences
Organisation/Company Institute of Human Genetics of the Polish Academy of Sciences Research Field Medical sciences » Health sciences Researcher Profile Recognised Researcher (R2) Positions PhD Positions Country Poland Application Deadline 15 Nov 2025 - 16:00 (Europe/Warsaw) Type of Contract Permanent Job Status Full-time Hours Per Week 40 Offer Starting Date 1 Dec 2025 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
ANNOUNCEMENT OF THE COMPETITION FOR A SCIENTIFIC POSITION
The Director of the Institute of Human Genetics, Polish Academy of Sciences in Poznan (IHG PAS) announces an open competition for the position of an post-doc (adjunct)
at theIndependent Research Group of RNA Biologyof the IHG PAS
The competition is open to persons who meet the conditions set out in the Act of 30 April 2010 on the Polish Academy of Sciences (Journal of Laws of 2020, item 1796, as amended) and the Regulations for conducting competitions for scientific positions at the Institute of Human Genetics, Polish Academy of Sciences in Poznan.
The project is carried out within the OPUS22 grant from the National Science Centre, Poland, project leader dr hab. n. med. Kamila Kusz‑Zamelczyk
Project title: “The role of NANOS3 in modulating genetic processes of early human germ cell development and implication in the human reproductive health”
Research Description:
Reproductive failures affect about 15% of couples worldwide. They are caused by, among others, mutations that disrupt the development of germ cells, which in turn is a risk factor for the occurrence of germline cancers. Dysfunction of NANOS3 gene is one of the cause of infertility. The NANOS3 protein, an RNA-binding protein and post-transcriptional regulator of gene expression, is a marker of germ cells, starting from the earliest stage of their development – specification. This stage of germ cell development, which takes place in early embryogenesis, is poorly understood, and RNAs regulated by NANOS3 at this stage of development have not yet been described.
The general goal of the project is to identify RNA molecules regulated by the NANOS3 protein and entire pathways underlying the early stages of germ cell development, in particular those that are altered by the NANOS3 p.Glu120Lys (v‑NANOS3) mutation associated with infertility. The specific goals are as follows: 1. Modification of human pluripotent stem cell lines (hPSCs) using CRISPR/Cas9 technology to develop cell lines for: a) induced degradation of NANOS3 protein (degron), b) identification of RNA molecules bound by NANOS3 of wild type and v‑NANOS3 (TRIBE, STAMP). These lines will then be differentiated into primordial germ cell like cells (hPGCLCs), which will serve as material for further studies on NANOS3 2. Identification of genes whose expression is regulated by NANOS3 and v‑NANOS3 at early stages of human germ cell development using whole transcriptome RNA sequencing (RNA‑Seq). 3. Identification of RNAs directly regulated by NANOS3 compared to v‑NANOS using TRIBE. 4. Confirmation of NANOS3 regulation and interaction with selected most interesting RNAs by RT‑qPCR, western blot, luciferase reporter assay.
The project “The role of NANOS3 in modulating genetic processes of early human germ cell development and implication in the human reproductive health” is carried out within OPUS22 grant from the National Science Centre Poland.
Key responsibilities:
Requirements for candidates:
A list of documents that the candidate should attach to the competition application:
Criteria for the evaluation of candidates
Research Field Medical sciences » Health sciences
Additional comments
Announcement of results Up to 30 days from the deadline for submitting documents
Selected candidates will be invited for an interview. Each of the submitted candidates will receive individual information about the results the in relation to their person. Information on the winner of the competition will be provided on the Institutes website
Information on the possibility of appeal of a candidate who has been negatively evaluated by the competition committee
Candidates who have been negatively evaluated by the Competition Commission have the right to appeal against the results of the assessment. The appeal is submitted to the Director of the Institute within 7 days from the date of receipt of negative feedback from the selection board. The decision of the Director of the Institute is final.
Number of offers available 1 Company/Institute Institute of Human Genetics of the Polish Academy of Sciences Country Poland State/Province Wielkopolska City Poznań Postal Code 60-479 Street Strzeszyńska 32 Geofield